Morning Wire
Morning Wire

Nov 21, 2026 · 20 min

Counterfeit GLP-1 drugs reach teenagers through gray markets

Parents Warned About Teens' New Drug Obsession

The episode examines how unapproved weight-loss products expose adolescents to unknown doses, contamination risks, and intensified body-image pressures.

3 key takeaways
  1. 1Teenagers are finding counterfeit retatrutide through social media, convenience stores, med spas, and other gray-market channels.
  2. 2Unapproved products may contain dangerous contaminants or unpredictable doses, while their effects on growing bodies remain unknown.
  3. 3Penny Nance urges parents to discuss looksmaxxing, body image, and drug use openly while involving medical professionals.

Don't miss

Penny Nance warns that counterfeit retatrutide may be contaminated or dangerously dosed, then turns to direct parental conversations about body image and drug use.

The brief

Morning Wire examines how teenagers are pursuing counterfeit weight-loss and beauty drugs, with Georgia Howe previewing an interview about the risks surrounding retatrutide.

Penny Nance describes looksmaxxing and the online marketing of illegal retatrutide, an investigational drug whose counterfeit versions may be contaminated or dangerously dosed.

The products can move through social media, convenience stores, med spas, and the mail, while teenagers use coded language and conceal their purchases from adults.

Nance distinguishes medically supervised GLP-1 treatment from unsupervised use, emphasizing that the effects of gray-market products on growing bodies remain unknown.

Her advice is practical but demanding: parents should address body image and drug use directly, seek medical guidance, and stay involved before secrecy becomes harm.

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.